MUC1-DERIVED PEPTIDE, AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF CANCER, IMMUNITY-INDUCING AGENT AND METHOD FOR MANUFACTURING ANTIGEN PRESENTING CELL USING SAME

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20200181195A1
SERIAL NO

16795391

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a peptide that includes eight or more consecutive amino acid residues of amino acid sequence of one of Sequence ID Nos. 1 to 12 and that consists of eleven or less amino acid residues.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NEC CORPORATION7-1 SHIBA 5-CHOME MINATO-KU TOKYO 108-8001

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
HAZAMA, SHOICHI UBE-SHI, JP 13 5
MIYAKAWA, TOMOYA TOKYO, JP 26 45
OKA, MASAAKI YAMAGUCHI-SHI, JP 91 1320
TAMADA, KOJI UBE-SHI, JP 45 171
UDAKA, KEIKO NANKOKU-SHI, JP 22 42

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation